electroCore (ECOR) is a US-listed Healthcare company in Medical - Devices with a market capitalization of $53M, trading at $6.33 on the NASDAQ. This SniperIQ fundamentals page covers electroCore's valuation, profitability (net margin -44.1%), revenue (
electroCore (ECOR) has a market capitalization of approximately $53M, trading at $6.33 on the NASDAQ. Market cap moves with the live share price.
electroCore runs a net profit margin of -44.1%, a gross margin of 87.2%, and an operating margin of -42.0%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
electroCore reported revenue of
electroCore does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
electroCore carries a debt-to-equity ratio of -1.67x and a current ratio of 1.02x, with a market beta of 0.89. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For electroCore (ECOR) the key facts are: market cap $53M, revenue
Get electroCore's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.